{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:21:51Z","timestamp":1740126111501,"version":"3.37.3"},"reference-count":18,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T00:00:00Z","timestamp":1420675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["P33983"],"award-info":[{"award-number":["P33983"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2015,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cardiovascular complications represent the biggest cause of mortality in acromegaly. It is therefore important to optimally stratify acromegalic patients according to disease activity and complication risk. <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> is secreted in a pulsatile manner from the pituitary gland, but <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> pulsatility is not routinely assessed clinically. The coefficient of variation of serum <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">GHCV<\/jats:styled-content>) during oral glucose tolerance test (OGTT) quantifies the variation of <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> secretion in patients with acromegaly, but has not been reported previously.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To investigate whether <jats:styled-content style=\"fixed-case\">GHCV<\/jats:styled-content> during <jats:styled-content style=\"fixed-case\">OGTT<\/jats:styled-content> is associated with clinical parameters predicted to relate with hypothalamo\u2010pituitary dysfunction during acromegaly, such as radiotherapy treatment, pituitary deficiency and cardiac disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">GHCV<\/jats:styled-content> was calculated during 584 <jats:styled-content style=\"fixed-case\">OGTT<\/jats:styled-content>s and compared with nadir serum <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">IGF<\/jats:styled-content>\u20101 in 111 acromegalic patients treated at a single centre.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Acromegalic patients treated with radiotherapy had a 37% lower level of <jats:styled-content style=\"fixed-case\">GHCV<\/jats:styled-content> when compared to the nonradiotherapy group (mean <jats:styled-content style=\"fixed-case\">GHCV<\/jats:styled-content>: 0\u00b7298\u00a0\u00b1\u00a00\u00b7015, no radiotherapy; 0\u00b7189\u00a0\u00b1\u00a00\u00b7007, radiotherapy; <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b7001). Neither serum <jats:styled-content style=\"fixed-case\">IGF<\/jats:styled-content>\u20101 nor nadir <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> was significantly altered in the radiotherapy group. Mean <jats:styled-content style=\"fixed-case\">GHCV<\/jats:styled-content> was 50% lower in the acromegalic patients with cardiac failure when compared to acromegalic patients with normal echocardiogram (0\u00b7161\u00a0\u00b1\u00a00\u00b7034 <jats:italic>vs<\/jats:italic> 0\u00b7297\u00a0\u00b1\u00a00\u00b7055; <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b705). Neither serum <jats:styled-content style=\"fixed-case\">IGF<\/jats:styled-content>\u20101 nor nadir <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> was significantly altered during cardiac failure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our preliminary data suggest that <jats:styled-content style=\"fixed-case\">GHCV<\/jats:styled-content> during <jats:styled-content style=\"fixed-case\">OGTT<\/jats:styled-content> may be reduced during acromegaly in patients with previous radiotherapy, pituitary deficiencies and cardiac disease. Larger studies are required to determine whether <jats:styled-content style=\"fixed-case\">GHCV<\/jats:styled-content> could provide help to assess the morbidity status of patients with treated acromegaly.<\/jats:p><\/jats:sec>","DOI":"10.1111\/cen.12685","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T08:26:22Z","timestamp":1417422382000},"page":"870-875","source":"Crossref","is-referenced-by-count":1,"title":["Associations of coefficient of variation of serum <scp>GH<\/scp> with previous radiotherapy, hypopituitarism and cardiac disease in patients with treated acromegaly"],"prefix":"10.1111","volume":"82","author":[{"given":"Channa N.","family":"Jayasena","sequence":"first","affiliation":[{"name":"Section of Investigative Medicine Hammersmith Hospital Imperial College London London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chioma","family":"Izzi\u2010Engbeaya","sequence":"additional","affiliation":[{"name":"Section of Investigative Medicine Hammersmith Hospital Imperial College London London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakunthala","family":"Narayanaswamy","sequence":"additional","affiliation":[{"name":"Section of Investigative Medicine Hammersmith Hospital Imperial College London London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Modi","sequence":"additional","affiliation":[{"name":"Section of Investigative Medicine Hammersmith Hospital Imperial College London London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly","family":"Clarke","sequence":"additional","affiliation":[{"name":"Section of Investigative Medicine Hammersmith Hospital Imperial College London London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurjinder M.K.","family":"Nijher","sequence":"additional","affiliation":[{"name":"Section of Investigative Medicine Hammersmith Hospital Imperial College London London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Meeran","sequence":"additional","affiliation":[{"name":"Section of Investigative Medicine Hammersmith Hospital Imperial College London London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waljit S.","family":"Dhillo","sequence":"additional","affiliation":[{"name":"Section of Investigative Medicine Hammersmith Hospital Imperial College London London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,1,8]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1210\/er.2002-0022"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(96)90083-9"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2002.122167"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0821"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031199"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04019.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-81-1-11"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030967"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-70-5-1375"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2002"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2104"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1371"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031584"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1097"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02340.x"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031601"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.56.5.863"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcen.12685","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.12685","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T17:04:36Z","timestamp":1695575076000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cen.12685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,8]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.1111\/cen.12685"],"URL":"https:\/\/doi.org\/10.1111\/cen.12685","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"type":"print","value":"0300-0664"},{"type":"electronic","value":"1365-2265"}],"subject":[],"published":{"date-parts":[[2015,1,8]]}}}